Welcome to our dedicated page for ChronoScale Holdings SEC filings (Ticker: CHRN), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on ChronoScale Holdings's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into ChronoScale Holdings's regulatory disclosures and financial reporting.
ChronoScale Holdings Corp (CHRN) filed its annual report outlining a major transformation into a focused AI cloud infrastructure provider. The company now operates primarily through its Cloud Business, which rents GPU capacity in third-party colocation centers in Colorado, Minnesota, and Utah and serves high-performance AI and machine learning workloads.
Cloud services, delivered via 6,144 deployed NVIDIA H100 GPUs and about 14 MW of colocation capacity, generated approximately 99.5% of total revenue for the year ended May 31, 2026, but currently come from a single customer, Together AI, under a 12‑month contract that auto‑renews in 60‑day increments. The legacy Ekso exoskeleton segment is classified as held for sale and reported as discontinued operations, with divestiture expected in fiscal 2027.
ChronoScale reported consolidated net losses of $50.3 million in fiscal 2026 and $72.7 million in 2025 and expects to raise additional capital, implying future dilution. The company highlights growth initiatives including a two‑year strategic partnership with Microsoft to support roughly 50 MW of new AI compute, a strategic partnership with Nutanix, and an expanded platform roadmap (NeoCloud infrastructure, GPU‑as‑a‑Service, Token Factory, and ChronoScale Foundry). Key risks include customer and supplier concentration, financing needs, execution risk on large deployments, potential penalties if Microsoft milestones are missed, heavy regulation around AI infrastructure, and dependence on Applied Digital as a controlling shareholder.
ChronoScale Holdings Corp (CHRN) disclosed a new Offer of Continued Employment for Jerome Wong, Chief Financial Officer of subsidiary ChronoScale Corporation, effective August 16, 2026. The agreement sets an annual base salary of $400,000 and eligibility for an annual performance bonus targeted at 60% of base salary, plus a cash “true-up” for the period from May 5, 2026 through August 16, 2026.
Mr. Wong is also contemplated to receive 300,000 restricted stock units (RSUs) with time-based vesting, approved by the board’s Compensation Committee. Upon a Qualifying CIC Termination during the Change in Control Period, he would receive cash severance equal to nine months of base salary, up to nine months of subsidized health coverage, and accelerated vesting of the initial RSU tranche. If later terminated without Cause outside that context, he would receive cash severance equal to six months of base salary, paid as salary continuation, in each case subject to a release of claims and ongoing compliance with restrictive covenants.
ChronoScale Holdings Corp (CHRN) reported that its Chief Financial Officer, Jerome Wong, received a grant of 300,000 restricted stock units (RSUs) on August 16, 2026. These RSUs convert into common shares on a one-for-one basis, have no expiration date, and vest one-third on May 5, 2027, with additional one-sixth installments every six months until full vesting on May 5, 2029, subject to continued service and potential accelerated vesting under certain conditions.
After this award, Wong holds 364,771 shares of common stock directly, which include 40,000 shares from vested performance-based RSUs and 24,771 shares from previously granted RSUs adjusted for a 1-for-15 reverse stock split, plus 4,184 shares indirectly via a 401(k) plan.
Jegannathan Rajasekar reported acquisition or exercise transactions in this Form 4 filing.
ChronoScale Holdings Corp Chief Technology Officer Jegannathan Rajasekar received a grant of 1,400,000 restricted stock units on July 22, 2026. The RSUs represent a contingent right to common shares and vest from June 1, 2027 through June 1, 2029, subject to continuous service, bringing his direct holdings to 1,402,587 shares.
ChronoScale Holdings Corp reports the initial equity holdings of Chief Technology Officer Jegannathan Rajasekar. As of 2026-07-19, he directly owns 2,587.0000 shares of Common Stock; the report characterizes this as a holding entry rather than a new transaction.
Chen Ying Cenly reported acquisition or exercise transactions in this Form 4 filing.
ChronoScale Holdings Corp granted Chief Executive Officer Chen Ying Cenly 2,800,000 restricted stock units (RSUs) tied to its common stock on July 13, 2026. The RSUs have no expiration date and vest one-third on May 1, 2027, then in equal six-month installments until fully vested on May 1, 2029, subject to continuous service and possible accelerated vesting under certain conditions. Following the award, Cenly’s reported direct beneficial ownership is 2,800,000 shares.
ChronoScale Holdings Corporation filed a pre-effective amendment to an S-3 registration covering the resale of 1,097,509 shares of common stock previously issued or issuable from private placements. These shares include common issued or issuable upon conversion of Series B preferred stock and exercise of investor and placement agent warrants.
The company will not receive proceeds from sales by the selling stockholders. ChronoScale now operates primarily a cloud business providing GPU-based infrastructure for AI and machine learning workloads, alongside its Legacy Ekso exoskeleton segment, which is classified as held for sale with divestiture targeted by the first fiscal quarter of 2027.
The filing also reflects ChronoScale Holdings’ status as successor issuer after a July 2026 Nevada holding company reorganization and describes significant risks, including large historical net losses, dependence on a single cloud customer expected to represent 99.5% of revenue for the year ended May 31, 2026, reliance on a few GPU suppliers, expected future capital needs and potential shareholder dilution.
ChronoScale Corporation is registering 1,097,509 shares of common stock for resale by selling stockholders pursuant to this prospectus. The resale covers shares issuable upon conversion and warrants from private placements, and the company will receive no proceeds from these resales.
The prospectus lists the sources of the Shares as: 15,389 2025 Placement Agent Warrant Shares; 711,922 Conversion Shares from Series B Preferred conversions; 355,960 Investor Warrant Shares; and 14,238 2026 Placement Agent Warrant Shares. The prospectus states there were 145,214,825 shares outstanding as of June 25, 2026.
Schaap Andrew Cordell reported acquisition or exercise transactions in this Form 4 filing.
ChronoScale Corp director Andrew Cordell Schaap received an equity grant of 200,000 shares of Common Stock as restricted stock. The grant was made on June 29, 2026 at a stated price of $0.00 per share and brings his reported direct holdings to 200,000 shares.
The award vests in two equal installments: 100,000 restricted shares vest on the one-year anniversary of the June 29, 2026 grant date and 100,000 restricted shares vest on the two-year anniversary. Vesting requires his continuous service with ChronoScale through each vesting date, with potential adjustment or accelerated vesting under certain conditions.